- Home
- SNV vs CORT Comparison
SNV vs CORT Comparison
Compare SNV & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNV
- CORT
- Stock Information
- Founded
- SNV 1888
- CORT 1998
- Country
- SNV United States
- CORT United States
- Employees
- SNV N/A
- CORT N/A
- Industry
- SNV Major Banks
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- SNV Finance
- CORT Health Care
- Exchange
- SNV Nasdaq
- CORT Nasdaq
- Market Cap
- SNV 7.2B
- CORT 7.6B
- IPO Year
- SNV N/A
- CORT N/A
- Fundamental
- Price
- SNV $52.16
- CORT $79.80
- Analyst Decision
- SNV Buy
- CORT Strong Buy
- Analyst Count
- SNV 22
- CORT 4
- Target Price
- SNV $59.05
- CORT $139.00
- AVG Volume (30 Days)
- SNV 1.7M
- CORT 720.7K
- Earning Date
- SNV 10-15-2025
- CORT 10-29-2025
- Dividend Yield
- SNV 3.01%
- CORT N/A
- EPS Growth
- SNV 218.56
- CORT N/A
- EPS
- SNV 5.20
- CORT 1.11
- Revenue
- SNV $2,239,379,000.00
- CORT $716,080,000.00
- Revenue This Year
- SNV $30.04
- CORT $30.62
- Revenue Next Year
- SNV $5.35
- CORT $37.68
- P/E Ratio
- SNV $9.97
- CORT $71.25
- Revenue Growth
- SNV 32.95
- CORT 25.71
- 52 Week Low
- SNV $35.94
- CORT $40.15
- 52 Week High
- SNV $61.06
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- SNV 57.38
- CORT 68.64
- Support Level
- SNV $49.51
- CORT $69.03
- Resistance Level
- SNV $52.69
- CORT $74.79
- Average True Range (ATR)
- SNV 1.17
- CORT 2.93
- MACD
- SNV 0.02
- CORT 0.73
- Stochastic Oscillator
- SNV 75.28
- CORT 98.97
About SNV Synovus Financial Corp.
Synovus Financial Corp provides commercial and consumer banking in addition to a full suite of specialized products & services such as private banking, treasury management, wealth management, mortgage services, premium finance, asset-based lending, structured lending, capital markets, & international banking to clients through the wholly-owned subsidiary bank, Synovus Bank, and other offices in Alabama, Florida, Georgia, South Carolina, and Tennessee. It has four segments Wholesale Banking, Community Banking, Consumer Banking, and Financial Management Services, out of which the majority is from the Wholesale banking segment.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.